These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17044060)
41. Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas. Vauhkonen H; Vauhkonen M; Sipponen P; Knuutila S Cytogenet Genome Res; 2007; 119(1-2):39-45. PubMed ID: 18160780 [TBL] [Abstract][Full Text] [Related]
42. The genetic differences between gallbladder and bile duct cancer cell lines. Saito S; Ghosh M; Morita K; Hirano T; Miwa M; Todoroki T Oncol Rep; 2006 Nov; 16(5):949-56. PubMed ID: 17016576 [TBL] [Abstract][Full Text] [Related]
43. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines. Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710 [TBL] [Abstract][Full Text] [Related]
44. [Comparative genomic hybridization for analysis of chromosomal changes in cisplatin-resistant ovarian cancer]. Kudoh K; Takano M; Koshikawa T; Yoshida S; Hirai M; Kikuchi Y; Nagata I; Miwa M; Uchida K Hum Cell; 2000 Sep; 13(3):109-16. PubMed ID: 11197772 [TBL] [Abstract][Full Text] [Related]
45. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH. Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930 [TBL] [Abstract][Full Text] [Related]
46. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. Choi YW; Choi JS; Zheng LT; Lim YJ; Yoon HK; Kim YH; Wang YP; Lim Y Lung Cancer; 2007 Jan; 55(1):43-51. PubMed ID: 17109992 [TBL] [Abstract][Full Text] [Related]
47. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. Roman E; Meza-Zepeda LA; Kresse SH; Myklebost O; Vasstrand EN; Ibrahim SO Oncol Rep; 2008 Oct; 20(4):825-43. PubMed ID: 18813824 [TBL] [Abstract][Full Text] [Related]
48. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Ishkanian AS; Mallof CA; Ho J; Meng A; Albert M; Syed A; van der Kwast T; Milosevic M; Yoshimoto M; Squire JA; Lam WL; Bristow RG Prostate; 2009 Jul; 69(10):1091-100. PubMed ID: 19350549 [TBL] [Abstract][Full Text] [Related]
49. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways. Körner M; Burckhardt E; Mazzucchelli L J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676 [TBL] [Abstract][Full Text] [Related]
50. Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas. Vékony H; Röser K; Löning T; Ylstra B; Meijer GA; van Wieringen WN; van de Wiel MA; Carvalho B; Kok K; Leemans CR; van der Waal I; Bloemena E Genes Chromosomes Cancer; 2009 Feb; 48(2):202-12. PubMed ID: 19009612 [TBL] [Abstract][Full Text] [Related]
51. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Suzuki S; Moore DH; Ginzinger DG; Godfrey TE; Barclay J; Powell B; Pinkel D; Zaloudek C; Lu K; Mills G; Berchuck A; Gray JW Cancer Res; 2000 Oct; 60(19):5382-5. PubMed ID: 11034075 [TBL] [Abstract][Full Text] [Related]
52. Identification of DNA copy number aberrations by array comparative genomic hybridization in patients with ruptured intracranial aneurysms. Choi JS; Kim SR; Jeon YW; Lee KH; Rha HK J Clin Neurosci; 2009 Feb; 16(2):295-301. PubMed ID: 19056275 [TBL] [Abstract][Full Text] [Related]
53. Clinical factors and biomarkers in ovarian tumors development. Vrabie CD; Petrescu A; Waller M; Dina I Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637 [TBL] [Abstract][Full Text] [Related]
55. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis. Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278 [TBL] [Abstract][Full Text] [Related]
56. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897 [TBL] [Abstract][Full Text] [Related]
57. Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues. Takeda M; Kasai T; Enomoto Y; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Nonomura A J Clin Pathol; 2012 Jan; 65(1):77-82. PubMed ID: 22081786 [TBL] [Abstract][Full Text] [Related]
58. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study. Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729 [TBL] [Abstract][Full Text] [Related]
59. Comparative proteomic analysis of advanced serous epithelial ovarian carcinoma: possible predictors of chemoresistant disease. Kim SW; Kim S; Nam EJ; Jeong YW; Lee SH; Paek JH; Kim JH; Kim JW; Kim YT OMICS; 2011 May; 15(5):281-92. PubMed ID: 21332407 [TBL] [Abstract][Full Text] [Related]
60. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Schwaenen C; Viardot A; Berger H; Barth TF; Bentink S; Döhner H; Enz M; Feller AC; Hansmann ML; Hummel M; Kestler HA; Klapper W; Kreuz M; Lenze D; Loeffler M; Möller P; Müller-Hermelink HK; Ott G; Rosolowski M; Rosenwald A; Ruf S; Siebert R; Spang R; Stein H; Truemper L; Lichter P; Bentz M; Wessendorf S; Genes Chromosomes Cancer; 2009 Jan; 48(1):39-54. PubMed ID: 18828156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]